Key Takeaways from the CDDF Webinar on Perspectives on the new EU Health Technology Assessment HTA Regulation 2021/2282 (28 September 2023)
The Cancer Drug Development Forum (CDDF) held a live webinar on “Perspectives on the new EU Health Technology Assessment HTA Regulation 2021/2282 “ on Thursday 28 September 2023. In this webinar, Marcus Guardian and Julie Spony provided an overview of the topic...Executive Summary of the Workshop on “Innovative Oncology Trial Designs” (September 2023, Amsterdam)
The Cancer Drug Development Forum (CDDF) has published its executive summary of the workshop on “Innovative Oncology Trial Designs.” The multi-stakeholder workshop took place on 18 – 19 September 2023 in Amsterdam, NL. The gathering brought together the...
CDDF Workshop on Innovative Oncology Trial Designs: Key Takeaways from Day 1’s Program
📢 The Cancer Drug Development Forum (CDDF) workshop on “Innovative Oncology Trial Designs” concluded successfully on its first day, bringing together key stakeholders in cancer drug development for in-depth discussions on a range of topics. Here are key takeaways and...Key Takeaways from the CDDF Webinar on Critical Impacts of the IVDR Implementation on Patient Access to Clinical Trials (7 September 2023)
The Cancer Drug Development Forum (CDDF) held a live webinar on “Critical Impacts of the In Vitro Diagnostic Regulation (IVDR) Implementation on Patient Access to Clinical Trials“ on Thursday 07 September 2023. In this webinar, Audrey Wolf (EFPIA) presented the...